Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 249 entries
View as:

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01041482 Org: User:
Start: 11/30/08 End: 11/30/13 Due: 11/30/14

Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03933319 Org: User:
Start: 03/11/19 End: 05/01/22 Due: 05/01/23

Felodipine Event Reduction Study

Phase: N/A Priority: Normal
NCT ID: NCT01136863 Org: User:
Start: 04/30/98 End: 06/30/04 Due: 06/30/05

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

Phase: N/A Priority: Normal
NCT ID: NCT04447274 Org: User:
Start: 07/01/20 End: 12/31/21 Due: 12/31/22

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02858206 Org: User:
Start: 06/30/16 End: 11/30/21 Due: 11/30/22

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Phase: N/A Priority: Normal
NCT ID: NCT01378533 Org: User:
Start: 05/31/11 End: 06/30/13 Due: 06/30/14

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01268943 Org: User:
Start: 11/30/10 End: 01/31/14 Due: 01/31/15

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02829008 Org: User:
Start: 04/30/16 End: 04/30/20 Due: 04/30/21

Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05235100 Org: User:
Start: 09/01/21 End: 12/31/24 Due: 12/31/25

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT01526850 Org: User:
Start: 02/29/12 End: 06/30/14 Due: 06/30/15

Comparison of Two Bending Angles for Nasotracheal Intubation With a Malleable Vedio Stylet

Phase: N/A Priority: Normal
NCT ID: NCT04459481 Org: User:
Start: 06/04/20 End: 11/05/20 Due: 11/05/21

A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03939871 Org: User:
Start: 12/12/17 End: 12/12/20 Due: 12/12/21

Sequence of Radiation and Targeted Therapy in Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04832672 Org: User:
Start: 10/01/10 End: 03/01/21 Due: 03/01/22

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Phase: N/A Priority: Normal
NCT ID: NCT01797900 Org: User:
Start: 03/31/13 End: 09/30/14 Due: 09/30/15

Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03427684 Org: User:
Start: 05/01/16 End: 12/31/20 Due: 12/31/21

Real World Study of MPM in China

Phase: N/A Priority: Normal
NCT ID: NCT05042557 Org: User:
Start: 06/01/21 End: 12/20/22 Due: 12/20/23

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03971214 Org: User:
Start: 06/30/19 End: 06/30/21 Due: 06/30/22

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02934828 Org: User:
Start: 10/31/14 End: 12/31/18 Due: 12/31/19

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01187238 Org: User:
Start: 05/31/10 End: 10/31/17 Due: 10/31/18

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Phase: N/A Priority: Normal
NCT ID: NCT05287308 Org: User:
Start: 03/31/22 End: 09/30/27 Due: 09/30/28

Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01413269 Org: User:
Start: 06/30/10 End: 09/30/18 Due: 09/30/19

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

Phase: N/A Priority: Normal
NCT ID: NCT03927898 Org: User:
Start: 03/01/19 End: 09/01/21 Due: 09/01/22

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01531452 Org: User:
Start: 06/30/11 End: 06/30/13 Due: 06/30/14

A Hospital Based Survey on Lung Cancer Related-pain in Northern China

Phase: N/A Priority: Normal
NCT ID: NCT03189277 Org: User:
Start: 06/30/17 End: 09/30/17 Due: 09/30/18

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

Phase: N/A Priority: Normal
NCT ID: NCT01134523 Org: User:
Start: 05/31/10 End: 05/31/20 Due: 05/31/21